Nexia Biotechnologies to reorganize into oil and gas company
Nexia Biotechnologies Inc. announced that the Board of Directors has completed its previously announced assessment of corporate assets. Nexia's management has been instructed to proceed immediately with a reorganization strategy to enhance shareholder value. The conceptual transaction structure will protect the value of the PharmAthene and BioSteel assets, and at the same time allow shareholders to participate in the oil and gas industry.
David Tonken, President of Nexia, commented, "We have determined that it is in Nexia's best interests to reorganize the company while demand for public vehicles containing Nexia's attributes remains strong. Our management has particular expertise in designing and executing such transactions, including the successful conversion of Synsorb Biotech Inc. into what is now Iteration Energy Ltd. We will likely reorganize Nexia within the context of a Plan of Arrangement. This would ultimately result in Nexia shareholders holding a pro-rata interest in two corporate entities. The first, an undiluted interest in a wholly owned subsidiary, which would hold the biotech assets, and the second, an interest in Nexia, which would be made available to a new oil and gas management team seeking to use a public vehicle to raise money and acquire additional assets. Shareholders will be fully informed with our progress as this effort develops."
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
New Business Development Appointments Strengthen ClinPhone's Operations
Hepcidin
Category:Medical_Council_of_India
Prionics Acquires CEDI Diagnostics - Strategic Partnership With Life Science Innovation Centre
MagForce Selected as Winner of 2010 STEP Award in the Category Product/Technology - Prize awarded in recognition of company's innovation and growth potential
List_of_subjects_in_Gray's_Anatomy:_XI._Splanchnology
MagForce AG Announces Changes to Supervisory and Management Boards
Adipose-Derived Stem & Regenerative Cells Improve Fat Graft Retention in Preclinical Study

No chance for environment-relieving plastic decomposition by bacteria - Burst Hope
